A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?. Issue 9 (20th May 2020) - Ciccarese, Mariangela; Orlando, Laura; Fedele, Palma; Schiavone, Paola; Maiello, Evaristo; Cilenti, Giuseppina; Aieta, Michele; Bozza, Giovanni; Forcignanò, Rosachiara; Febbraro, Antonio; Bordonaro, Roberto; Romito, Sante; et al.